BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

  Latest News

Chiba University Researchers Develop Low-Cost Cell-Based Assay to Detect Chemical-Induced Epigenetic Changes

by BiopharmaTrend   •   April 11, 2025  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Researchers at Chiba University, in collaboration with Japan’s National Institute of Health Sciences, have developed a novel cell-based assay that detects epigenetic changes induced by environmental chemicals—a capability not addressed by standard genotoxicity tests. 

The study, published in Scientific Reports (March 2025), introduces the epi-TK reporter assay, which quantifies both gene silencing and reactivation in response to chemical exposure using site-specific DNA methylation of the thymidine kinase (TK) promoter.

#advertisement
AI in Drug Discovery Report 2025

The assay was shown to detect global epigenetic changes following treatment with DNA methyltransferase inhibitors and non-genotoxic carcinogens like TPA. It captures dynamic shifts in DNA methylation and histone acetylation, providing a more complete picture of chemical-induced gene regulation.

Unlike sequencing-based epigenetic analysis, which is expensive and technically demanding, this approach suggests a low-cost, scalable alternative suitable for use in low-resource settings. According to the researchers, it could improve chemical risk assessment, particularly for compounds found in food, cosmetics, and industrial materials linked to carcinogenesis and other health effects.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.